Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. [electronic resource]
Producer: 20080102Description: 1089-93 p. digitalISSN:- 0891-3668
- Adolescent
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antiviral Agents -- administration & dosage
- Child
- Child, Preschool
- Drug Therapy, Combination
- Female
- Hospitals, Pediatric
- Humans
- Immunocompromised Host
- Infant
- Infant, Newborn
- Injections, Intravenous
- Male
- Palivizumab
- Respiratory Syncytial Virus Infections -- drug therapy
- Respiratory Syncytial Virus, Human -- drug effects
- Ribavirin -- administration & dosage
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.